Will the reclassification of marijuana from a Schedule I to a Schedule III drug disrupt the cannabis marketplace?
What consequences must industry stakeholders consider if the Drug Enforcement Administration's proposal...more
A major update in cannabis law was announced by the Drug Enforcement Administration (DEA) and Attorney General (AG) this past Tuesday, April 30, 2024 regarding their intent to ease restrictions on cannabis. The DEA plans to...more
5/6/2024
/ Agribusiness ,
Biden Administration ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Dispensaries ,
Legalization ,
Marijuana ,
Marijuana Related Businesses ,
Medical Foods ,
Medical Marijuana ,
Pharmacies ,
Plant Based Products ,
Regulatory Reform ,
Retail Market ,
State and Local Government
As of September 25, 2023, Bill A4151 was approved by the New Jersey Senate and is now law in New Jersey. This approved bill amends the existing New Jersey recreational cannabis regulatory landscape. Bill A4151, or P.L. 2023,...more
2/8/2024
/ Agribusiness ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Dispensaries ,
Investment ,
Investors ,
License Applications ,
Licensing Rules ,
Marijuana ,
Marijuana Related Businesses ,
New Amendments ,
New Jersey ,
Recreational Use ,
State and Local Government